Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Ventyx Biosciences Inc (NASDAQ: VTYX) was $9.07 for the day, down -2.89% from the previous closing price of $9.34. In other words, the price has decreased by -$2.89 from its previous closing price. On the day, 0.7 million shares were traded. VTYX stock price reached its highest trading level at $9.53 during the session, while it also had its lowest trading level at $8.86.
Ratios:
Our analysis of VTYX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.86 and its Current Ratio is at 17.86. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On March 12, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7 to $16. Oppenheimer Upgraded its Perform to Outperform on March 12, 2024, while the target price for the stock was maintained at $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 18 ’25 when Mohan Raju sold 47,345 shares for $7.72 per share. The transaction valued at 365,461 led to the insider holds 2,372,863 shares of the business.
Nuss John sold 12,675 shares of VTYX for $97,840 on Dec 18 ’25. The CHIEF SCIENTIFIC OFFICER now owns 489,481 shares after completing the transaction at $7.72 per share. On Dec 18 ’25, another insider, Nuss John, who serves as the Officer of the company, bought 12,675 shares for $7.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 647222848 and an Enterprise Value of 464608832.
Stock Price History:
The Beta on a monthly basis for VTYX is 1.23, which has changed by 3.0085835 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, VTYX has reached a high of $10.55, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 13.49%, while the 200-Day Moving Average is calculated to be 151.04%.
Shares Statistics:
VTYX traded an average of 4.38M shares per day over the past three months and 1564960 shares per day over the past ten days. A total of 71.34M shares are outstanding, with a floating share count of 64.07M. Insiders hold about 10.21% of the company’s shares, while institutions hold 62.17% stake in the company. Shares short for VTYX as of 1764288000 were 5424203 with a Short Ratio of 1.24, compared to 1761868800 on 6149971. Therefore, it implies a Short% of Shares Outstanding of 5424203 and a Short% of Float of 8.08.
Earnings Estimates
Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of Ventyx Biosciences Inc (VTYX) in the stock market.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.35 and -$1.57 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.61, with 7.0 analysts recommending between -$1.14 and -$2.1.
